课题基金 / 基金详情

Dissecting the alphavirus entry receptor NRAMP

Dissecting the alphavirus entry receptor NRAMP
剖析甲病毒进入受体 NRAMP
批准号:
8677683
负责人:
Sara Cherry
金额:
$46.59万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-07-01 至 2016-06-30

项目摘要

项目成果

Sara Cherry的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Alphavirus interactions with cellular receptors are likely to play a major role determining viral tropism and driving virus-induced disease. However, the viral receptors that mediate alphavirus entry are poorly understood. A genome wide screen using Sindbis virus identified NRAMP as a potential alphavirus entry receptor in insect cells. Additional studies suggest that NRAMP is also an entry receptor for Venezuelan Equine Encephalitis virus. Furthermore, in mammalian cells the ubiquitously expressed homolog, NRAMP2, can mediate infection of these alphaviruses. Our long-term goal is to dissect the role of NRAMPs in infectivity and pathogenesis of alphaviruses with the goal of developing strategies to combat these pathogens. We will study this important interaction from both the perspective of the viruses and their varied hosts, including studies to determine whether additional alphaviruses use NRAMP as a receptor and to define the regions of the viral glycoproteins that mediate NRAMP binding. Since mammals have two homologous genes, NRAMP1 and NRAMP2, we will also test whether NRAMP1 and NRAMP2 can functionally substitute for one another as alphavirus entry receptors and test whether one or both of these molecules is required for alphavirus infection in primary cells from diverse lineages and in vivo. We will take advantage of powerful assays that we have developed to study alphavirus entry and infection both in insect and mammalian cells and extend these studies to mice and adult flies to explore the role of NRAMPs in viral pathogenesis and spread. Our central hypothesis is that dissecting the interactions of these medically important arboviruses with their receptor will reveal mechanisms that will aid in the development of antiviral treatments against these understudied pathogens for which there are no vaccines or therapeutics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development and validation of antivirals against Flaviviruses
  • 批准号:
    10514328
  • 项目类别:
  • 资助金额:
    $489.76万
  • 财政年份:
    2022
  • 负责人:
    Sara Cherry
  • 依托单位:
Defining the role of microbiota-derived cyclic dinucleotides in priming antiviral immune defenses.
  • 批准号:
    10551893
  • 项目类别:
  • 资助金额:
    $40.63万
  • 财政年份:
    2020
  • 负责人:
    Sara Cherry
  • 依托单位:
Small Molecule Screening to Identify Novel Sars-CoV-2 Therapeutics
  • 批准号:
    10223018
  • 项目类别:
  • 资助金额:
    $33.6万
  • 财政年份:
    2020
  • 负责人:
    Sara Cherry
  • 依托单位:
Defining the role of microbiota-derived cyclic dinucleotides in priming antiviral immune defenses.
  • 批准号:
    10326823
  • 项目类别:
  • 资助金额:
    $40.63万
  • 财政年份:
    2020
  • 负责人:
    Sara Cherry
  • 依托单位:
海外基金